Production (Stage)
Oncolytics Biotech Inc.
ONC.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.65M | 11.08M | 14.51M | 18.16M | 21.86M |
| Total Receivables | 61.90K | 47.30K | 77.00K | 1.15M | 75.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 1.31M | 1.57M | 2.46M | 2.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 848.80K | 681.10K | 808.30K | 619.60K | 460.10K |
| Total Current Assets | 12.86M | 13.12M | 16.96M | 22.38M | 24.65M |
|
|
|||||
| Total Current Assets | 12.86M | 13.12M | 16.96M | 22.38M | 24.65M |
| Net Property, Plant & Equipment | 845.30K | 911.80K | 998.60K | 1.05M | 1.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.71M | 14.03M | 17.96M | 23.43M | 25.66M |
|
|
|||||
| Total Accounts Payable | 542.00K | 755.50K | 2.54M | 647.40K | 549.40K |
| Total Accrued Expenses | 2.90M | 2.58M | 2.59M | 2.75M | 2.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 201.80K | 192.50K | 185.80K | 164.40K | 132.20K |
| Total Finance Division Other Current Liabilities | 368.70K | 1.12M | 362.00K | 919.90K | 231.90K |
| Total Other Current Liabilities | 368.70K | 1.12M | 362.00K | 919.90K | 231.90K |
| Total Current Liabilities | 4.01M | 4.65M | 5.67M | 4.48M | 3.03M |
|
|
|||||
| Total Current Liabilities | 4.01M | 4.65M | 5.67M | 4.48M | 3.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 494.00K | 547.00K | 601.80K | 651.00K | 700.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.68M | 4.68M | 4.98M | 4.92M | 4.97M |
| Total Liabilities | 9.19M | 9.87M | 11.26M | 10.05M | 8.70M |
|
|
|||||
| Common Stock & APIC | 340.86M | 335.50M | 353.90M | 349.06M | 350.93M |
| Retained Earnings | -337.01M | -332.01M | -347.68M | -336.21M | -334.46M |
| Treasury Stock & Other | 666.50K | 667.90K | 483.40K | 527.50K | 494.80K |
| Total Common Equity | 4.52M | 4.16M | 6.70M | 13.38M | 16.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.52M | 4.16M | 6.70M | 13.38M | 16.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.52M | 4.16M | 6.70M | 13.38M | 16.96M |
|
|
|||||